OptiBac Probiotics Revenue and Competitors
Estimated Revenue & Valuation
- OptiBac Probiotics's estimated annual revenue is currently $15.3M per year.
- OptiBac Probiotics's estimated revenue per employee is $243,000
Employee Data
- OptiBac Probiotics has 63 Employees.
- OptiBac Probiotics grew their employee count by 9% last year.
OptiBac Probiotics Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 0 | N/A | N/A | N/A |
#2 | $21.6M | 80 | -1% | N/A | N/A |
#3 | $102.3M | 303 | -2% | N/A | N/A |
#4 | $18M | 74 | -16% | N/A | N/A |
#5 | $7.6M | 35 | -39% | N/A | N/A |
#6 | $21.9M | 81 | -2% | N/A | N/A |
#7 | $908M | 2402 | 7% | N/A | N/A |
#8 | $121.2M | 359 | -1% | N/A | N/A |
#9 | $15.6M | 64 | -4% | N/A | N/A |
#10 | $138.7M | 411 | -3% | N/A | N/A |
What Is OptiBac Probiotics?
OptiBac Probiotics is the UK's best-selling probiotic range. Specialising in probiotics such as L. acidophilus, OptiBac Probiotics have a range of probiotic products, using different strains to target different health conditions, such as bloating, diarrhoea, immunity, children's health and travel health. The entire range is free from artificial sweeteners and flavourings, and also much more potent than probiotic yoghurts or yoghurt drinks.
keywords:N/AN/A
Total Funding
63
Number of Employees
$15.3M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OptiBac Probiotics News
Health brands now manufacture probiotics that purport to boost our vaginal health. There's OptiBac "For women", Canesten's "Canesflor probiotics for vaginal ...
Wren Laboratories Ltd is the company behind OptiBac Probiotics, the UK & Ireland's most popular brand of probiotic supplements*.
Probiotics have been touted as a treatment for a huge range of conditions, from obesity to mental health problems. One of their popular uses is ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 64 | 10% | N/A |
#2 | $17.6M | 70 | N/A | N/A |
#3 | $15.4M | 70 | 9% | N/A |
#4 | $7.8M | 72 | 33% | N/A |
#5 | $7.9M | 77 | N/A | N/A |